Capecitabine, DNA/RNA Synthesis Inhibitor
Por um escritor misterioso
Descrição
Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.
TAS1553, a small molecule subunit interaction inhibitor of ribonucleotide reductase, exhibits antitumor activity by causing DNA replication stress
DNA and RNA Synthesis: Antifolates
Emerging strategies for cancer therapy by ATR inhibitors - Yano - 2023 - Cancer Science - Wiley Online Library
Capecitabine API Manufacturer and Supplier
How Do Antibiotics Affect Nucleic Acid Synthesis?, Biomol Blog, Resources
Capecitabine, C15H22FN3O6
Capecitabine, DNA/RNA Synthesis Inhibitor
Design of Novel Potent Inhibitors of Human Uridine Phosphorylase-1: Synthesis, Inhibition Studies, Thermodynamics, and in Vitro Influence on 5-Fluorouracil Cytotoxicity
Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response
Capecitabine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
